Trytosaveabit
OP72506401
:
Thats awesome! Im happy but you gotta give yourself credit as well! You decided to trade it! I dont give buy/sell advice! And im very careful with my wording with things like this! And its not that i dont want to. Its because i have NO WAY to know others risk tolerance. Or how they will trade it. And there is also me being wrong! Because, believe me im definitely fallible. Hehehe. Being honest, if i know 100% that a ticker would go up. And knew exactly how much. I would give that to all my followers. Anyways sorry so long a answer to just say CONGRATS on a great trade! Hehehe WTG
$ALX Oncology (ALXO.US)$ALX Oncology Presents Positive Updated Data From ASPEN-06 Phase 2 Trial Demonstrating Evorpacept Generates Strong Response and Durable Clinical Benefit in Patients With HER2-Positive Gastric Cancer GlobeNewswire· 6 mins ago
$ALX Oncology (ALXO.US)$ ALX Oncology Presents Positive Updated Data from ASPEN-06 Phase 2 Trial Demonstrating Evorpacept Generates Strong Response and Durable Clinical Benefit in Patients with HER2-Positive Gastric Cancer Thursday, 23rd January at 8:00 am • Oral presentation at 2025 ASCO Gastrointestinal Cancers Symposium today highlights evorpacept as the first CD47 blocker to show substantial tumor response and a well-tolerated safety profile in a prospective randomized trial • Greatest ...
$ALX Oncology (ALXO.US)$ ALX Oncology to Host Virtual Company Event Highlighting Updated Data from ASPEN-06 Phase 2 Trial Presented at 2025 ASCO GI Tuesday, 21st January at 5:00 pm • Webcast on January 23 at 1:00 p.m. PT/4:00 p.m. ET will review updated data from trial evaluating CD47-blocker evorpacept in HER2-positive gastric cancer SOUTH SAN FRANCISCO, Calif., Jan. 21, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., ("ALX Oncology" or the "Company") (NASDAQ: ALXO), a clinical-stage ...
1
Report
No comment yet
Sign in to post a comment
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
ALX Oncology Stock Forum
GlobeNewswire· 6 mins ago
ALX Oncology Presents Positive Updated Data from ASPEN-06 Phase 2 Trial Demonstrating Evorpacept Generates Strong Response and Durable Clinical Benefit in Patients with HER2-Positive Gastric Cancer
Thursday, 23rd January at 8:00 am
• Oral presentation at 2025 ASCO Gastrointestinal Cancers Symposium today highlights evorpacept as the first CD47 blocker to show substantial tumor response and a well-tolerated safety profile in a prospective randomized trial
• Greatest ...
ALX Oncology to Host Virtual Company Event Highlighting Updated Data from ASPEN-06 Phase 2 Trial Presented at 2025 ASCO GI
Tuesday, 21st January at 5:00 pm
• Webcast on January 23 at 1:00 p.m. PT/4:00 p.m. ET will review updated data from trial evaluating CD47-blocker evorpacept in HER2-positive gastric cancer
SOUTH SAN FRANCISCO, Calif., Jan. 21, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., ("ALX Oncology" or the "Company") (NASDAQ: ALXO), a clinical-stage ...
No comment yet